
Getting screened regularly for cancers is the best way to diagnose them early and to identify precancerous conditions. Regular screening via our extensive array of screening tests will help in the early diagnosis of the disease leading to early treatment.
The various cancer screening tests available at Tapadia Diagnostics include:
Digital mammography
Digital X ray
Ultrasound screening
32 slice Siemens CT scan
1.5 Tesla MRI scan
Flowcytometry tests
Leukemia and lymphoma panels
Cervical PAP smear
Fine needle aspiration cytology
Ultrasound guided Fine needle aspiration cytology
Histopathology services
Immunohistochemistry services
Early detection significantly improves clinical outcomes in oncological care. Tapadia Diagnostic provides advanced cancer screening protocols and diagnostic biomarker assays designed to detect precancerous changes, localized tumors, and systemic malignancies in their earliest stages.
Serum Tumor Markers: Quantitative assays including Prostate-Specific Antigen (PSA) for prostate screening, CA-125 for ovarian assessment, CA 19-9 for pancreatic and GI evaluation, and Carcinoembryonic Antigen (CEA) for colorectal monitoring.
Digital Mammography & Breast Ultrasound: High-resolution low-dose digital imaging for early detection of breast lumps, microcalcifications, and tissue density variations in women.
Cytopathology & FNAC: Fine Needle Aspiration Cytology and cervical Pap Smears for evaluating accessible lumps and cervical cellular health.
Cross-Sectional Imaging: Multi-slice CT scans and high-field 1.5T MRI for detailed anatomical tumor localization and staging.
Screening tests are recommended periodically based on age, family medical history, and clinical risk factors. Consult your physician to determine the most appropriate cancer screening protocol for your health profile.























